Connect with us

Cannabis News

Minnesota Hemp Businesses And Senators Say Federal THC Ban Will Hurt The State’s Economy

Published

10 months ago

on

“Senator Klobuchar voted against the hemp provision because he believed it would hurt the state’s small businesses.”

By Ana Radelat, MinnPost

Minnesota has a growing industry of intoxicating hemp products, including soft drinks and gummies. A product ban making its way through Congress in a bill that would reopen the federal government.

The bill gives the industry 365 days before all products containing more than 0.4 milligrams of THC (a trace) are outlawed. Christopher Lackner, president of the Hemp Beverages Alliance, hopes to give the industry time to push back against the provision, which he called “arbitrary” and “punitive.”

He said he’s betting on “the pushback from consumers, suppliers and distributors and everyone else in the supply chain” that a ban on THC-infused products made from hemp will cause.

“Our hope as an industry is that Congress will come back and meet with all the stakeholders and build a federal hemp beverage framework that worksLackner said.

The 2018 Farm Bill legalized hemp, removing it from the federal definition of marijuana under the Controlled Substances Act and treating it as an agricultural commodity. It also opened the doors to the production of “modifying” products derived from hemp.

Minnesota led the nation in harnessing the redefinition of hemp. Whitney Economics’ Latest report on THC beverages It estimated total US THC beverage sales to exceed $1.1 billion in 2024, and Minnesota was a key state in that growth.

Success has come at a price, however. Competing industries, mostly the nation’s nascent legal marijuana industry and, more recently, the beer and spirits industries, furiously lobbied to shut down what they saw as “the loophole”. in the 2018 Farm Bill that has led to an explosion of hemp-infused products.

The marijuana and alcohol industries say hemp products are largely unregulated and some contain dangerous amounts of THC. They also say there are no labeling and marketing restrictions or efforts to keep THC-infused drinks and edibles away from children.

On Monday, the Beer Institute, the Distilled Spirits Council of the United States and other alcohol trade groups He sent a lobbying letter to members of CongressSen. Rand Paul, R-Ky., urging the rejection of an amendment that would have removed the bill’s blackout language.

“Producers of alcoholic beverages, one of the top consumer products, are asking the Senate to reject Paul’s attempts to allow hemp-derived THC products to be sold across the country without federal regulation and oversight,” the letter said.

Their argument won the day.

The legislation that would have ended the shutdown includes three appropriations bills in fiscal year 2026 to fund various government agencies, including the U.S. Department of Agriculture, where the hemp provision was inserted. All other federal agencies would receive short-term funding — through the end of January — under a continuing resolution, or CR.

While the hemp industry lost the lobbying battle, it gained supporters in the US Capitol. Paul, for example, blocked Senate GOP leaders from getting unanimous approval to fast-track the shutdown bill, which overcame a six-week Democratic gridlock on a 60-40 vote Sunday afternoon.

The US Senate voted to table—or reject—the Paul amendment, 76-24. Senators Amy Klobuchar (D) and Tina Smith (D) of Minnesota were in the minority in support of the effort to remove the hemp language.

“Senator Klobuchar voted against the hemp provision because he believed it would harm the state’s small businesses and because Congress’ efforts to regulate hemp products should take into account states like Minnesota that already have strong regulations,” a Klobuchar spokesperson said.

Lackner also said lawmakers in Congress were trampling on states’ rights to regulate intoxicating hemp products.

“This is a slap in the face to states like Minnesota that have developed regulatory frameworks based on stakeholder input,” he said.

The hemp switch is wrong from every angle‘

Steve Brown, CEO of Nothing but Hemp, a Northeast Minneapolis-based company that makes THC-infused gummies and drinks, brewery emulsions and a variety of other hemp-based products, said the shutdown bill could spur a move into the marijuana industry.

That said, if President Donald Trump signs the legislation, as expected, the manufacture and sale of its products will be illegal under federal law, and it will have a major impact on its market.

Brown said liquor stores could not offer any of his drinks on the shelves. Microbreweries, which have tried to combat declining beer sales by offering THC drinks that are more popular than alcohol among young people, would be breaking federal law if they continued to offer such libations.

And retail stores, including Target, would likely stop selling THC-infused drinks and other products because customers wouldn’t be able to pay for them with credit cards due to federal banking rules.

Shipping THC-infused products across state lines would also be against federal law.

“I think it’s wrong from every angle,” Brown said of the hemp provision in the shutdown legislation.

Brown said he manufactures about 2 million cans a year and that his THC-infused beverage operation is small compared to other Minnesota companies.

He said he started his business in a kiosk with a sign that read “Try CBD,” a non-intoxicating hemp ingredient that is praised for its medicinal value. If hemp-infused drinks and edibles are outlawed, Brown says he’s preparing to turn Nothing but Hemp, which has 60 employees, into a marijuana business.

Jim Taylor, a spokesman for the Minnesota Office of Cannabis Management, said “any draft or proposed (hemp) language is being reviewed to see its impact on Minnesota.”

“This is a complex policy issue, and we are reviewing it with the Attorney General,” Taylor said.

Just signed by Minnesota Attorney General Keith Ellison a letter They said unregulated THC products pose a threat to the general public along with 38 other attorneys general.

David Ladd, president of the Minnesota Industrial Hemp Association, said his group has tried to be as neutral as possible on the issue. But he said the state’s hemp growers also don’t want to “stifle innovation and investment” in hemp, which can be used to produce a variety of products, including biofuels, paper and textiles.

“I get regulations and sponsors for hemp products,” Ladd said. “But an arbitrary change in the definition of hemp is no substitute for measured regulation.”

The US Senate gave final approval to the shutdown bill late Monday. The legislation now heads to the US House, where Minnesota’s Democratic House members are expected to join the state’s two Democratic senators — Klobuchar and Smith — to reject the legislation.

So the longest government shutdown is on its way to an end after eight moderate Democrats in the US Senate dropped their opposition to the bill. GOP leaders said they offered a fair deal because the legislation would protect programs from Trump’s budget cuts and the Affordable Care Act subsidy extension promised by Senate Leader John Thune (R-SD) in exchange for Democrats’ votes to reopen the government.

This led to an onslaught of criticism from Democratic colleagues and Democratic voters.

Rep. Angie Craig, D-2. Barrutiko, for example, posted on social media “If people think this is a ‘deal’, I have a bridge to sell you.”

This the article appeared for the first time MinnPost and is republished here under a Creative Commons Attribution-NoDerivs 4.0 International License.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Related Topics:
Continue Reading

Cannabis News

Fluent to sell New York license and operations

Published

1 month ago

on

July 30, 2026

By











Fluent has entered into a definitive agreement to sell Etain, LLC, the Company’s New York-based operating entity. The purchase agreement was signed on July 22, 2026. The transaction provides for the sale of Etain’s Registered Entity license, certain of the Company’s New York operating assets and related New York leases for cash, subject to customary purchase price adjustments.

The Company believes the Transaction advances its strategic objectives and expects the Transaction to comply with applicable regulatory requirements in connection with the Company’s previously announced plan of arrangement for Vireo Growth Inc. (the “Deal”) while providing for an orderly transition of the New York operations to an experienced operator committed to serving patients and consumers.

Completion of the free transaction is subject to closing conditions, including, among other customary conditions, approval of the change in ownership by the New York State Cannabis Control Board and the completion of all conditions to the completion of the Agreement.

For more information:
FLUENT Corp
getfluent.com/










Continue Reading

Cannabis News

Marijuana Has ‘Horrific Health Risks’ And No Medical Value, Former Trump Attorney General Claims

Published

1 month ago

on

July 30, 2026

By

A former US attorney general who served in President Donald Trump’s first term says marijuana poses “tremendous health risks,” has no medical value and should not be rescheduled under federal law.

“Marijuana redistricting would create a false impression that it is safe, reduce penalties for illegally selling the drug, and provide a large tax windfall to those who legally supply it,” William Barr wrote in a Wednesday op-ed for The Washington Post, Kevin Sabet, CEO of the prohibitionist organization Smart Approaches to Marijuana. “That would be a disaster.”

The opinion comes as the Trump administration moves forward with cannabis reregulation.

According to an order issued in April by US Attorney General Todd Blanche, Marijuana products regulated by a state medical cannabis license were immediately changed from Schedule I As did marijuana products approved by the Food and Drug Administration (FDA) under Schedule III of the Controlled Substances Act (CSA).

an administrator The hearing is looking at the broader rescheduling of marijuanawith The Drug Enforcement Administration (DEA) has been tasked with advocating for cannabis reform highlighting the testimony about the medical benefits of marijuana and its relative safety compared to other substances such as alcohol and opioids. It included appearances by a Food and Drug Administration (FDA) scientist and a doctor from New Hampshire. Medical marijuana provides relief to pain patients and can serve as an alternative to opioids.

But Sabet and Barr, who served as Trump’s attorney general from 2019-2020, argued that “the evidence presented at the hearing did not support the rescheduling of marijuana” and instead “confirmed what decades of data have shown: raw marijuana has no scientifically established medical value and is highly susceptible to abuse.”

After the parties to the hearing have filed termination rights, the DEA administrative law judge overseeing the proceedings will make a recommendation regarding rescheduling, and the agency administrator will make a final decision.

DEA Administrator Terrance Cole only organizations and individuals opposed to marijuana reform have been invited to the hearing as a designated participant – telling supporters that they do not meet the definition of “interested person” to participate because they have not been “affected or prejudiced by any rule or proposed rule that may be issued.”

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

The former attorney general’s new opinion says “the stakes couldn’t be higher”, arguing that “marijuana today is more dangerous than ever” and that it is “addictive”, throwing out a list of alleged harm to mental and physical health.

“These unhealthy effects are a predictable result of a powerful and addictive drug being normalized, commercialized and marketed as a medicine,” Barr and Sabet say. “It would be one thing if marijuana had medical value. But there is no credible evidence that marijuana is an effective treatment for any medical condition, despite the millions of dollars spent trying to prove otherwise.”

The Department of Health and Human Services (HHS) published a 252 analysis in 2023 that concluded that marijuana had accepted medical value and should be rescheduled.

The new opposition piece also says that “rescheduling would unlock enormous revenue for the corporate marijuana industry by bringing it into a category that has not been covered by a longstanding reduction in federal drug tax deductions,” referring to a law known as 280E, which repeals Sections I and II.

“This, in turn, would allow the industry to spend even more on advertising and marketing to young people,” Barr and Sabet. he wroteArguing that “those who would lose this dragon in society are laying the foundations for another Big Tobacco”.

The Sabet organization, SAM, is one of several parties Challenging the Marijuana Redistricting Process which have been upheld by a federal Court of Appeals. those separate parts State attorneys general have filed lawsuits against cannabis reform, Opponents of marijuana legalization and a a cannabis-based biopharmaceutical corporation.

SAM’s lawsuit was signed by attorneys at Torridon Law PLLC, where Barr is a partner.

The team announced in January that it was Hiring Barr’s firm to fight cannabis rescheduling After Trump signed an executive order directing officials to quickly complete the process.

During the first Trump administration, Barr was accused by a Justice Department official Directing improper anti-company investigations into multiple cannabis company mergers– Accounting for almost a third of the division’s cases in 2019.

Several Democratic members of Congress introduced a resolution calling for an investigation into Barr’s possible impeachment, saying “abused the power of his office” to improperly investigate marijuana businesses while engaging in other allegedly illegal conduct.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

How much red light does cannabis really need?

Published

1 month ago

on

July 26, 2026

By

When growers pull out two LED fixtures side by side, the first number they usually discuss is percent red. This is an easy specification to fix. They are efficient at producing red photons and incredibly efficient at photosynthesis, and cannabis eats away at the flower. So more red must be better, right?

Not so simple. Red is an input to a spectrum, and the spectrum is an input to a room. There is no single spectrum that wins everywhere. An indoor room pushes hard, a greenhouse that soaks up sunlight, a temperamental cultivar, and aggressive yields call for something different. Knowing what each light strip actually does allows you to choose a tool that fits your grow instead of one that just has a big number on the sales page.

© JumpLights

Blue: structure
Blue (approximately 400-500 nm) gives shape to the plant. It maintains dense growth, strong stems, tight internodes and allows it to develop as desired. It also encourages stomatal opening, so the plant manages water and gas exchange better. Get blue and you’ve built a plant that can carry heavy flowers with no problem.

Green: access
Green was eliminated as the wavelength is “reflected” by plants. It turns out that it does a real job. Blue and red are absorbed above; the green goes deep into the fat and reaches the leaves that are never touched by the above photons. In a compact room, it’s the difference between plants photosynthesising from the top down and those that work only from the top. Green won’t replace your red or blue, but it does carry usable light where they can’t reach.

Red: engine
Red is the horse of the flower. It absorbs as efficiently as anything in the spectrum, and is responsible for most of the biomass you’re after. Redder generally means faster flower development, more weight and better efficiency per watt.

But red has a ceiling, and it’s tied to what you run. Push PPFD upwards with a heavy red spectrum and some cultivars begin to whiten at the top: the flower should be dense with pale, washed tips. Genetics, intensity, barrel temperature and your general environment all feed into it. If you’re using aggressive light levels, a lower red spectrum will buy you room before that becomes a problem, leaving you almost no photosynthetic punch to get it.

Far Red: More than Emerson
Far-red (700-750 nm) appears in more devices every year. It contributes little to photosynthesis on its own, but it moves plant morphology and works with red through the Emerson Enhancement Effect. Used properly, it helps to deepen the light, encourage uniformity of the canopy and encourage the response of the bloom. The key word is small. A touch of far red rounds out a spectrum; he’s not there to make a show.

Matching the red percentage with the room
Cannabis addresses the entire spectrum, not a line on a spec sheet. Reds cause flowers, but blues, greens and crimsons give the plant something it needs. Where you land in red refers to how you grow.

A lower red spectrum (30-40%) captures more blue and green, gives you better morphology, reduces the risk of photobleaching, and holds up when you’re running extreme PPFD. Moderate spectrum (40-55%) is the sweet spot in commercial greenhouses: strong photosynthetic efficiency, strong flowering, balanced growth. A high-red spectrum (70%+) makes the most sense in a greenhouse, where the sun is already giving you lots of blue and green and your supplemental light can cast effective red to fill the gap.

Where does the ETS MAX series fit in?
This is the thinking behind the JumpLights ETS MAX series. Instead of forcing a spectrum into each room, it rarely comes up because a greenhouse and a high PPFD indoor flower room are not the same problem.

  • ETS MAX 4C41% red: for indoor rooms operating at very high intensity, where photobleaching is a real risk. The wider, red bottom balance allows you to push the tops without overcooking them
  • ETS MAX 4A48% red: balanced internal spectrum that maintains high output while controlling bleaching.
  • ETS MAX 5B57% Red: A high-performance indoor option. Moderate red, marked with efficiency and flower at the same time, up to 3,450 μmol/s, with efficiency that holds the spectrum.
  • ETS MAX 7A76% red: built for the greenhouse. The sun already supplies blue and green, so this leans heavily on the complementary red, up to 3,900 μmol/s in the infrastructure most greenhouses already have in place.

Bottom line
Choosing an activity is not a competition for the highest red number. The winning spectrum is the one that matches your environment, your intensity, your genetics, and what you’re trying to produce. Combine spectrum, intensity, environmental control, light distribution and genetics, and you’ve got a lighting strategy. Keep a spec isolated and all you’ve got is a bright room.

The ETS MAX line was created around this idea: choose the spectrum of the room you actually have, indoor or greenhouse, and let the device work with your grow rather than against it.

For more information:
JumpLights
www.jumplights.com

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media